Neural mechanisms in primary hypertension: Efficacy of α-blockade with doxazosin during stress

American Journal of Hypertension

Volumn 9, Issue 1, 1996, Pages 47-53

  Lee, Deping ^a   Lu, Zhi Wen ^a   DeQuattro, Vincent ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Doxazosin; Primary hypertension; Sympathetic nervous system; Blocker

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; NOREPHEDRINE;

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG EFFICACY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; STRESS;

EID: 0030046261     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-7061(95)00261-8     Document Type: Article

References (24)

1. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Int Med 1993;153(2):154-183.
2. The Treatment of Mild Hypertension Research Group: The Treatment of Mild Hypertension Study. A randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies. Arch Intern Med 1991;151:1413-1423.
3. Neaton JD, Grimm RH, Prineas RJ, et al: Treatment of mild hypertension study. Final results. JAMA 1993;270: 713-724.
4. DeQuattro V, Lee DP: Physical stresses and pharmacologic manipulations: neurohumoral and hemodynamic responses in hypertension, in Schneiderman N, Weiss SM, Kaufmann PG (eds): Handbook of Research Methods in Cardiovascular Behavioral Medicine. Plenum Press, New York, 1989, pp 393-410.
5. DeQuattro V, Sullivan P, Minagawa R, Kopin I, Bornheimer J. Foti A, Barndt: Central and peripheral noradrenergic mechanisms in primary hypertension. Fed Proc 1984;43(1):47-51.
6. Lee DP, Kimura S, DeQuattro V, Davidson G: Relaxation therapy lowers blood pressure more effectively in hypertensives with raised plasma norepinephrine and blunts pressor response to anger. Clin Exp Hypertens [A] 1989;A11(suppl 1):191-198.
7. Rozanski A, Bairey CN, Krantz DS et al: Mental stress and the induction of silent myocardial ischemia in patients with coronary artery disease. New Engl J Med 1988;318:1100-1112.
8. Peuler JD, Johnson GA: Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epi nephrine and dopamine. Life Sci 1977;21(5):625-636.
9. Lee DP, Kimura S, DeQuattro V, Davison G: Relaxation therapy lowers blood pressure more effectively in hypertensives with raised plasma norepinephrine and blunts pressor response to anger. Clin Exp Hypertens [A] 1989;A11(suppl 1):191-198.
10. Francois B, Cahen R, Gravejat MF, Estrade M: Do beta blockers prevent pressor responses to mental stress and physical exercise? Eur Hypertens J 1984; 5:348-353.
11. DeQuattro V, Lee D: Blood pressure reactivity and sympathetic hyperactivity - predictors of hypertension. Am J Hypertens 1991;4:624S-628S.
12. Kusuka M, Atarashi K, Matsumoto K et al: Plasma renin activity and norepinephrine as predictors for anti-hypertensive effects of nifedipine and captopril. Am J Hypertens 1991;4:735-739.
13. DeQuattro V, Miura Y: Neurogenic factors in hypertension: mechanism or myth? Am J Med 1973;55:362-378.
14. Floras JS, Hassan O, Jones JV et al: Pressor responses to laboratory stresses and daytime blood pressure variability. J Hypertens 1987;5:715-719.
15. Siegel WC, Blumenthal JA, Divine GW: Physiological, psychological, and behavioral factors and white coat hypertension. Hypertension 1990;16:140-146.
16. Borghi C, Costa FV, Boschi S et al: Predictors of stable hypertension in young borderline subjects: a five-year follow-up study. J Cardiovasc Pharm 1986;8:S138-S141.
17. Light KC, Dolan CA, Davis MR et al: Cardiovascular responses to an active coping challenge as predictors of blood pressure patterns 10 to 15 years later. Psychosom Med 1992;54:217-230.
18. Manuck SB: Cardiovascular reactivity in cardiovascular disease: "once more unto the breach." Intl J Behavioral Med 1994;1(1):4-31.
19. Pickering TG, Levenstein M, Walmsley P: Nighttime dosing of doxazosin has peak effect on morning ambulatory blood pressure. Am J Hypertens 1994;7(9, pt 1): 844-847.
20. Singleton W, Caxton CAPD, Hernandez J, Prichard BNC: Postjunctional selectivity of alpha-blockade with prazosin, trimazosin and UK-33,274 in man. J Cardiovasc Pharmacol 1982;4:S145-S51.
21. Wilner KD, Ziegler MG: Effects of alpha 1 inhibition on renal blood flow and sympathetic nervous activity in systemic hypertension. Am J Cardiol 1987;59:82G-86G.
22. DeLeeuw PW, Van Es PN, De Bos R, Birkenhager WH: Acute renal effects of doxazosin in man. Br J Clin Pharmacol 1986;21:41S-43S.
23. Shionoiri H, Yasuda G, Oshimura H, et al: Antihypertensive effects and pharmacokinetics of single and consecutive administration of doxazosin in patients with mild to moderate essential hypertension. J Cardiovasc Pharm 1987;10:90-95.
24. Kolloch R, Dequattro V, Myers M, Bornheimer J: Plasma catecholamines during isometric exercise in patients with essential hypertension: effects of combined alpha- and beta-blockade, in Usdin E, Kvetnansky R, Kopin I (eds): Catecholamines and Stress: Recent Advances. Elsevier North-Holland, Amsterdam, 1980, pp 507-512.